Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1989 1
1992 1
1998 3
1999 2
2000 2
2001 2
2002 3
2003 3
2004 2
2005 3
2006 4
2007 3
2008 1
2009 2
2010 1
2011 4
2012 1
2013 2
2016 2
2017 3
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Stroke Associated With Recent Mycoplasma Pneumoniae Infection: A Systematic Review of Clinical Features and Presumed Pathophysiological Mechanisms.
Mélé N, Turc G. Mélé N, et al. Front Neurol. 2018 Dec 21;9:1109. doi: 10.3389/fneur.2018.01109. eCollection 2018. Front Neurol. 2018. PMID: 30622505 Free PMC article. Review.
Introduction: An association between Mycoplasma pneumoniae (MP) infection and stroke has been described, especially in children. ...Whether MP infection could be a long-term risk factor for stroke by promoting atherosclerosis is uncertain and deserves further invest …
Introduction: An association between Mycoplasma pneumoniae (MP) infection and stroke has been described, especially in children. ...W …
Comparison of the Protective Effects of Individual Components of Particulated trans-Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits.
Garavelo SM, Higuchi ML, Pereira JJ, Reis MM, Kawakami JT, Ikegami RN, Palomino SA, Wadt NS, Agouni A. Garavelo SM, et al. Biomed Res Int. 2017;2017:7212985. doi: 10.1155/2017/7212985. Epub 2017 Feb 27. Biomed Res Int. 2017. PMID: 28337456 Free PMC article.
PTCTS components combined were more effective against atherosclerosis than individual components. Our data reinforce the infectious theory of atherosclerosis and underscore the potential role of circulating MPs. Therefore, the removal of Mycoplasma-derived MP …
PTCTS components combined were more effective against atherosclerosis than individual components. Our data reinforce the infectious t …
Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients.
El Yazouli L, Seghrouchni F, Hejaji H, Bouazza M, Alami AA, Dakka N, Radouani F. El Yazouli L, et al. Microb Pathog. 2020 Feb;139:103860. doi: 10.1016/j.micpath.2019.103860. Epub 2019 Nov 7. Microb Pathog. 2020. PMID: 31707079
BACKGROUND: Chlamydia pneumoniae is an obligate intracellular bacterium that activates cell mediated immune responses; several investigations have demonstrated its strong implication in atherosclerosis. ...METHODS: This investigation involved a total of 27 patients with …
BACKGROUND: Chlamydia pneumoniae is an obligate intracellular bacterium that activates cell mediated immune responses; several investigation …
Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
Damy SB, Higuchi ML, Timenetsky J, Reis MM, Palomino SP, Ikegami RN, Santos FP, Osaka JT, Figueiredo LP. Damy SB, et al. BMC Microbiol. 2009 Sep 10;9:194. doi: 10.1186/1471-2180-9-194. BMC Microbiol. 2009. PMID: 19744321 Free PMC article.
BACKGROUND: Chamydophila pneumoniae (CP) and/or Mycoplasma pneumoniae (MP) are two bacteria detected in vulnerable atheromas. In this study we aimed to analyze whether CP and/or MP aggravates atherosclerosis induced by cholesterol-enriched diet in C57BL/6 apoE KO ma …
BACKGROUND: Chamydophila pneumoniae (CP) and/or Mycoplasma pneumoniae (MP) are two bacteria detected in vulnerable atheromas. In this …
[Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves].
Higuchi-Dos-Santos MH, Pierri H, Higuchi Mde L, Nussbacher A, Palomino S, Sambiase NV, Ramires JA, Wajngarten M. Higuchi-Dos-Santos MH, et al. Arq Bras Cardiol. 2005 Jun;84(6):443-8. doi: 10.1590/s0066-782x2005000600002. Epub 2005 Jun 28. Arq Bras Cardiol. 2005. PMID: 16007307 Free article. Portuguese.
OBJECTIVE: We investigated whether Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) are present in aortic valve stenosis (AS). ...This adds novel similarities between AS and the atherosclerosis process, which may have infection mechanisms involved....
OBJECTIVE: We investigated whether Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) are present in aortic valve stenosis (AS) …
Molecular characterisation of Chlamydia pneumoniae associated to atherosclerosis.
El Yazouli L, Criscuolo A, Hejaji H, Bouazza M, Elmdaghri N, Aroussi Alami A, Amraoui A, Dakka N, Radouani F. El Yazouli L, et al. Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx039. Pathog Dis. 2017. PMID: 28387800
The main objective of our study was to evaluate the association between Chlamydia pneumoniae and atherosclerosis in Moroccan patients through a case-control approach and detected strain genotyping. ...This study supports the involvement of Chlamydia pneumoniae in athero
The main objective of our study was to evaluate the association between Chlamydia pneumoniae and atherosclerosis in Moroccan patients …
No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.
Weiss TW, Kvakan H, Kaun C, Prager M, Speidl WS, Zorn G, Pfaffenberger S, Huk I, Maurer G, Huber K, Wojta J. Weiss TW, et al. J Clin Pathol. 2006 Nov;59(11):1186-90. doi: 10.1136/jcp.2005.034314. Epub 2006 Apr 27. J Clin Pathol. 2006. PMID: 16644879 Free PMC article.
BACKGROUND: That infections with certain pathogens, by initiating an inflammatory response, may contribute to the development of atherosclerosis is suggested by clinical and experimental evidence. AIM: To analyse atherosclerotic plaques of the carotid artery, samples of ap …
BACKGROUND: That infections with certain pathogens, by initiating an inflammatory response, may contribute to the development of atherosc
Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J; AtheroGene Investigators. Espinola-Klein C, et al. Circulation. 2002 Jan 1;105(1):15-21. doi: 10.1161/hc0102.101362. Circulation. 2002. PMID: 11772870
BACKGROUND: Recent findings suggest a causative role of infections in the pathogenesis of atherosclerosis. In hypothesizing an association between infectious agents and the development of atherosclerosis, we would expect a correlation to the extent of atheroscler
BACKGROUND: Recent findings suggest a causative role of infections in the pathogenesis of atherosclerosis. In hypothesizing an associ …
Trypanosoma cruzi trans-sialidase as a new therapeutic tool in the treatment of chronic inflammatory diseases: possible action against mycoplasma and chlamydia.
de Lourdes Higuchi M. de Lourdes Higuchi M. Med Hypotheses. 2004;63(4):616-23. doi: 10.1016/j.mehy.2004.03.043. Med Hypotheses. 2004. PMID: 15325005
We identified that mycoplasmas and chlamydias are present in atherosclerosis, aortic valve stenosis, dilated cardiomyopathy, chronic chagasic myocarditis and cancer. ...The proposal that trans-sialidase from T. cruzi is efficient in combating co-infection of myco
We identified that mycoplasmas and chlamydias are present in atherosclerosis, aortic valve stenosis, dilated cardiomyopathy, c …
47 results
Jump to page
Feedback